C-DIM12 is primarily researched for its potential therapeutic applications, particularly in the field of cancer treatment. It has shown promise in targeting nuclear receptors, specifically the orphan nuclear receptor Nur77, which plays a role in apoptosis (programmed cell death) in cancer cells. By modulating this receptor, C-DIM12 may induce cancer cell death while sparing normal cells, making it a candidate for developing targeted anticancer therapies. Additionally, it has been studied for its anti-inflammatory properties, potentially offering benefits in treating inflammatory diseases. Research is ongoing to explore its efficacy and safety in these areas.